20
Participants
Start Date
October 11, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
MPL-001
"CBD50 plus is a medical cannabis oil with flavouring agent produced under Good Manufacturing Practice by MediPharm Labs and purchased for this study. Each ml of oil contains 2 mg/ml of delta-9-THC and 50 mg/ml of CBD.~Participants will receive escalating doses from 0.2-0.4 mg/kg/day of CBD to 0.8-1 mg/kg of CBD per day for four months, with dose increases monthly in 0.2mg/kg increments. Participants will following a weekly weaning protocol."
NOT_YET_RECRUITING
University of British Columbia, Vancouver
NOT_YET_RECRUITING
Dalhousie University-, Halifax
RECRUITING
North Toronto Neurology, Toronto
SickKids Foundation
OTHER
University of Manitoba
OTHER